14-Aug-2026
No headlines found.
No press releases found.
No news found.
Virtus Biotech ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index (the "Underlying Index"). Under normal market conditions, the Fund will invest not less than 80% of its assets in component securities of the Underlying Index. The Underlying Index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing. The Underlying Index is sponsored by LifeSci Index Partners, LLC (the "Index Provider"). The Index Provider utilizes a selection committee comprised of its employees (the "Index Committee") that is responsible, pursuant to the rules included in the methodology for the Underlying Index, for making certain determinations for the Underlying Index, as more fully described below. The Index Committee utilizes various public data sources to make determinations, including, but not limited to, Securities and Exchange Commission ("SEC") filings, public documents from the U.S. Food and Drug Administration ("FDA"), company press releases and official corporate websites.
Virtus Biotech ETF trades on the ARCA stock market under the symbol BBP.
As of August 14, 2026, BBP stock price climbed to $101.31 with 11,203 million shares trading.
BBP has a market cap of $106.38 million. This is considered a Micro Cap stock.
In the last 3 years, BBP traded as high as $105.21 and as low as $45.00.
BBP has outperformed the market in the last year with a price return of +52.0% while the SPY ETF gained +21.5%. BBP has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +14.5% and +7.9%, respectively, while the SPY returned +4.0% and +3.9%, respectively.
BBP support price is $99.17 and resistance is $103.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BBP shares will trade within this expected range on the day.
